• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.

作者信息

Yang Jingyun, Wang Wei, Chen Zimin, Lu Shuaiyao, Yang Fanli, Bi Zhenfei, Bao Linlin, Mo Fei, Li Xue, Huang Yong, Hong Weiqi, Yang Yun, Zhao Yuan, Ye Fei, Lin Sheng, Deng Wei, Chen Hua, Lei Hong, Zhang Ziqi, Luo Min, Gao Hong, Zheng Yue, Gong Yanqiu, Jiang Xiaohua, Xu Yanfeng, Lv Qi, Li Dan, Wang Manni, Li Fengdi, Wang Shunyi, Wang Guanpeng, Yu Pin, Qu Yajin, Yang Li, Deng Hongxin, Tong Aiping, Li Jiong, Wang Zhenling, Yang Jinliang, Shen Guobo, Zhao Zhiwei, Li Yuhua, Luo Jingwen, Liu Hongqi, Yu Wenhai, Yang Mengli, Xu Jingwen, Wang Junbin, Li Haiyan, Wang Haixuan, Kuang Dexuan, Lin Panpan, Hu Zhengtao, Guo Wei, Cheng Wei, He Yanlin, Song Xiangrong, Chen Chong, Xue Zhihong, Yao Shaohua, Chen Lu, Ma Xuelei, Chen Siyuan, Gou Maling, Huang Weijin, Wang Youchun, Fan Changfa, Tian Zhixin, Shi Ming, Wang Fu-Sheng, Dai Lunzhi, Wu Min, Li Gen, Wang Guangyu, Peng Yong, Qian Zhiyong, Huang Canhua, Lau Johnson Yiu-Nam, Yang Zhenglin, Wei Yuquan, Cen Xiaobo, Peng Xiaozhong, Qin Chuan, Zhang Kang, Lu Guangwen, Wei Xiawei

机构信息

Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.

National Kunming High-level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan, China.

出版信息

Nature. 2021 Feb;590(7844):E23. doi: 10.1038/s41586-020-03108-4.

DOI:10.1038/s41586-020-03108-4
PMID:33469221
Abstract
摘要

相似文献

1
Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.出版商更正:一种靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白受体结合域(RBD)的疫苗可诱导保护性免疫。
Nature. 2021 Feb;590(7844):E23. doi: 10.1038/s41586-020-03108-4.
2
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.一种针对严重急性呼吸综合征冠状病毒 2 刺突蛋白 RBD 的疫苗可诱导保护性免疫。
Nature. 2020 Oct;586(7830):572-577. doi: 10.1038/s41586-020-2599-8. Epub 2020 Jul 29.
3
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.SARS-CoV-2 感染和 COVID-19 康复过程中抗 SARS-CoV-2 抗体的动态变化。
Nat Commun. 2020 Nov 27;11(1):6044. doi: 10.1038/s41467-020-19943-y.
4
Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.SARS-CoV-2 刺突蛋白的静态全原子能量映射和“向上”与“向下”构象状态的动态稳定性分析。
PLoS One. 2020 Nov 10;15(11):e0241168. doi: 10.1371/journal.pone.0241168. eCollection 2020.
5
Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection.构建并免疫研究一种 SARS-CoV-2 刺突蛋白的 mFc 融合受体结合域(RBD)作为针对 SARS-CoV-2 感染的亚单位疫苗。
Chem Commun (Camb). 2020 Aug 7;56(61):8683-8686. doi: 10.1039/d0cc03263h. Epub 2020 Jul 2.
6
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits.兔源 SARS-CoV-2 刺突蛋白免疫原诱导的抗体特征。
Sci Transl Med. 2020 Jul 1;12(550). doi: 10.1126/scitranslmed.abc3539. Epub 2020 Jun 8.
7
Immunoglobulin fragment F(ab') against RBD potently neutralizes SARS-CoV-2 in vitro.针对 RBD 的免疫球蛋白 F(ab') 片段在体外有力地中和了 SARS-CoV-2。
Antiviral Res. 2020 Oct;182:104868. doi: 10.1016/j.antiviral.2020.104868. Epub 2020 Jul 10.
8
Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.多种中东呼吸综合征冠状病毒(MERS-CoV)的重组受体结合结构域可诱导产生针对不同人类和骆驼MERS-CoV以及抗体逃逸突变体的交叉中和抗体。
J Virol. 2016 Dec 16;91(1). doi: 10.1128/JVI.01651-16. Print 2017 Jan 1.
9
Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.出版商更正:一种缺失辅助蛋白的减毒活新冠病毒候选疫苗。
Nat Commun. 2022 Oct 13;13(1):6060. doi: 10.1038/s41467-022-33878-6.
10
Publisher Correction: SARS-CoV-2 and the brain to be studied long-term.出版商更正:将对新冠病毒与大脑进行长期研究。
Nat Rev Neurol. 2021 Apr;17(4):260. doi: 10.1038/s41582-020-0407-6.

引用本文的文献

1
A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants.一种源自JN.1刺突蛋白的很有前景的mRNA疫苗可针对多种已出现的奥密克戎变体提供保护性免疫。
Mol Biomed. 2025 Mar 4;6(1):13. doi: 10.1186/s43556-025-00258-7.
2
XBB.1.16-RBD-based trimeric protein vaccine can effectively inhibit XBB.1.16-included XBB subvariant infection.基于XBB.1.16-RBD的三聚体蛋白疫苗可有效抑制包括XBB.1.16在内的XBB亚变体感染。
MedComm (2020). 2024 Aug 16;5(9):e687. doi: 10.1002/mco2.687. eCollection 2024 Sep.
3
A Modular Cloning Toolkit for the production of recombinant proteins in .
用于在……中生产重组蛋白的模块化克隆工具包
Microb Cell. 2024 Apr 30;11:128-142. doi: 10.15698/mic2024.04.821. eCollection 2024.
4
Nanoparticle vaccines based on the receptor binding domain of porcine deltacoronavirus elicit robust protective immune responses in mice.基于猪德尔塔冠状病毒受体结合域的纳米颗粒疫苗在小鼠中引发强烈的保护性免疫应答。
Front Immunol. 2024 Mar 14;15:1328266. doi: 10.3389/fimmu.2024.1328266. eCollection 2024.
5
Point-of-care CRISPR/Cas biosensing technology: A promising tool for preventing the possible COVID-19 resurgence caused by contaminated cold-chain food and packaging.即时护理CRISPR/Cas生物传感技术:预防受污染冷链食品和包装引发新冠疫情可能卷土重来的一项有前景的工具。
Food Front. 2022 Oct 12. doi: 10.1002/fft2.176.
6
Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.康复的 COVID-19 患者中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白特异性和中和抗体的长期持久性。
PLoS One. 2022 Apr 21;17(4):e0267102. doi: 10.1371/journal.pone.0267102. eCollection 2022.
7
A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains.一种高度保守的多肽疫苗候选物能激活针对 SARS-CoV-2 变异株的体液和细胞免疫。
Front Immunol. 2021 Dec 7;12:789905. doi: 10.3389/fimmu.2021.789905. eCollection 2021.